These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
|
|||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||
|
|
||||||||
|
|
|
|||||||
| (Address of principal executive offices) | (Zip Code) | |||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
|
|
|
|
||||||||||||
|
|
☒ | Accelerated filer | ☐ | |||||||||||||||||
| Non-accelerated filer | ☐ | Smaller reporting company |
|
|||||||||||||||||
| Emerging growth company |
|
|||||||||||||||||||
|
GXO Logistics, Inc.
|
||||||||
| Form 10-Q | ||||||||
|
For the Quarterly Period Ended March 31, 2025
|
||||||||
|
Table of Contents
|
||||||||
| Page | ||||||||
| Three Months Ended March 31, | ||||||||||||||||||||||||||
| (Dollars in millions, shares in thousands, except per share amounts) | 2025 | 2024 | ||||||||||||||||||||||||
| Revenue | $ |
|
$ |
|
||||||||||||||||||||||
| Direct operating expense |
|
|
||||||||||||||||||||||||
| Selling, general and administrative expense |
|
|
||||||||||||||||||||||||
| Depreciation and amortization expense |
|
|
||||||||||||||||||||||||
| Transaction and integration costs |
|
|
||||||||||||||||||||||||
| Restructuring costs and other |
|
|
||||||||||||||||||||||||
| Regulatory matter and litigation expense |
|
|
||||||||||||||||||||||||
| Operating loss |
(
|
(
|
||||||||||||||||||||||||
| Other income (expense), net |
(
|
|
||||||||||||||||||||||||
| Interest expense, net |
(
|
(
|
||||||||||||||||||||||||
| Loss before income taxes |
(
|
(
|
||||||||||||||||||||||||
| Income tax (expense) benefit |
(
|
|
||||||||||||||||||||||||
| Net loss |
(
|
(
|
||||||||||||||||||||||||
| Net income attributable to Noncontrolling Interests (“NCI”) |
(
|
(
|
||||||||||||||||||||||||
| Net loss attributable to GXO | $ |
(
|
$ |
(
|
||||||||||||||||||||||
| Loss per share | ||||||||||||||||||||||||||
| Basic | $ |
(
|
$ |
(
|
||||||||||||||||||||||
| Diluted | $ |
(
|
$ |
(
|
||||||||||||||||||||||
| Weighted-average shares used in computation of loss per share | ||||||||||||||||||||||||||
| Basic |
|
|
||||||||||||||||||||||||
| Diluted |
|
|
||||||||||||||||||||||||
| Three Months Ended March 31, | ||||||||||||||||||||||||||
| (In millions) | 2025 | 2024 | ||||||||||||||||||||||||
| Net loss | $ |
(
|
$ |
(
|
||||||||||||||||||||||
| Other comprehensive income (loss), net of tax | ||||||||||||||||||||||||||
| Foreign currency translation adjustments |
|
(
|
||||||||||||||||||||||||
| Cash flow hedges |
(
|
|
||||||||||||||||||||||||
| Pension plans |
(
|
|
||||||||||||||||||||||||
| Other comprehensive income (loss), net of tax |
|
(
|
||||||||||||||||||||||||
| Comprehensive loss, net of tax |
(
|
(
|
||||||||||||||||||||||||
| Less: Comprehensive income attributable to NCI |
|
|
||||||||||||||||||||||||
| Comprehensive loss attributable to GXO | $ |
(
|
$ |
(
|
||||||||||||||||||||||
| March 31, | December 31, | |||||||||||||
| (Dollars in millions, shares in thousands, except per share amounts) | 2025 | 2024 | ||||||||||||
| ASSETS | ||||||||||||||
| Current assets | ||||||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
||||||||||
|
Accounts receivable, net of allowance of $
|
|
|
||||||||||||
| Other current assets |
|
|
||||||||||||
| Total current assets |
|
|
||||||||||||
| Long-term assets | ||||||||||||||
|
Property and equipment, net of accumulated depreciation of $
|
|
|
||||||||||||
| Operating lease assets |
|
|
||||||||||||
| Goodwill |
|
|
||||||||||||
|
Intangible assets, net of accumulated amortization of $
|
|
|
||||||||||||
| Other long-term assets |
|
|
||||||||||||
| Total long-term assets |
|
|
||||||||||||
| Total assets | $ |
|
$ |
|
||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||
| Current liabilities | ||||||||||||||
| Accounts payable | $ |
|
$ |
|
||||||||||
| Accrued expenses |
|
|
||||||||||||
| Current debt |
|
|
||||||||||||
| Current operating lease liabilities |
|
|
||||||||||||
| Other current liabilities |
|
|
||||||||||||
| Total current liabilities |
|
|
||||||||||||
| Long-term liabilities | ||||||||||||||
| Long-term debt |
|
|
||||||||||||
| Long-term operating lease liabilities |
|
|
||||||||||||
| Other long-term liabilities |
|
|
||||||||||||
| Total long-term liabilities |
|
|
||||||||||||
|
Commitments and Contingencies (Note 14)
|
|
|
||||||||||||
| Stockholders’ Equity | ||||||||||||||
|
Common Stock, $
|
|
|
||||||||||||
|
Treasury stock, at cost;
|
(
|
|
||||||||||||
|
Preferred Stock, $
|
|
|
||||||||||||
| Additional Paid-In Capital (“APIC”) |
|
|
||||||||||||
| Retained earnings |
|
|
||||||||||||
| Accumulated Other Comprehensive Income (Loss) (“AOCIL”) |
(
|
(
|
||||||||||||
| Total stockholders’ equity before NCI |
|
|
||||||||||||
| NCI |
|
|
||||||||||||
| Total equity |
|
|
||||||||||||
| Total liabilities and equity | $ |
|
$ |
|
||||||||||
| Three Months Ended March 31, | ||||||||||||||
| (In millions) | 2025 | 2024 | ||||||||||||
| Cash flows from operating activities: | ||||||||||||||
| Net loss | $ |
(
|
$ |
(
|
||||||||||
|
Adjustments to reconcile net loss to net cash provided by operating activities
|
||||||||||||||
| Depreciation and amortization expense |
|
|
||||||||||||
| Stock-based compensation expense |
|
|
||||||||||||
|
Deferred tax benefit
|
(
|
(
|
||||||||||||
| Other |
|
|
||||||||||||
| Changes in operating assets and liabilities | ||||||||||||||
| Accounts receivable |
(
|
|
||||||||||||
| Other assets |
|
(
|
||||||||||||
| Accounts payable |
(
|
(
|
||||||||||||
| Accrued expenses and other liabilities |
|
|
||||||||||||
| Net cash provided by operating activities |
|
|
||||||||||||
| Cash flows from investing activities: | ||||||||||||||
| Capital expenditures |
(
|
(
|
||||||||||||
| Proceeds from sale of property and equipment |
|
|
||||||||||||
| Purchase of Wincanton plc shares |
|
(
|
||||||||||||
| Net cash used in investing activities |
(
|
(
|
||||||||||||
| Cash flows from financing activities: | ||||||||||||||
| Common stock repurchased |
(
|
|
||||||||||||
| Net borrowings under revolving credit facilities |
|
|
||||||||||||
| Repayments of finance lease obligations |
(
|
(
|
||||||||||||
| Taxes paid related to net share settlement of equity awards |
(
|
(
|
||||||||||||
| Other |
|
|
||||||||||||
| Net cash used in financing activities |
(
|
(
|
||||||||||||
| Effect of exchange rates on cash and cash equivalents |
|
(
|
||||||||||||
| Net decrease in cash, restricted cash and cash equivalents |
(
|
(
|
||||||||||||
| Cash, restricted cash and cash equivalents, beginning of period |
|
|
||||||||||||
|
Cash, restricted cash and cash equivalents, end of period
|
$ |
|
$ |
|
||||||||||
| Reconciliation of cash, restricted cash and cash equivalents | ||||||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
||||||||||
| Restricted Cash (included in Current assets) |
|
|
||||||||||||
| Restricted Cash (included in Other long-term assets) |
|
|
||||||||||||
| Total cash, restricted cash and cash equivalents | $ |
|
$ |
|
||||||||||
| Non-cash financing activities: | ||||||||||||||
| Unsettled stock repurchases for which trades occurred | $ |
|
$ |
|
||||||||||
| Excise tax liability related to stock repurchases | $ |
|
$ |
|
||||||||||
| Common Stock | APIC |
Retained
Earnings |
AOCIL |
Equity Before
NCI |
NCI |
Total
Equity |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
(Shares in thousands,
dollars in millions) |
Shares | Amount | Treasury Stock | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance as of December 31, 2024 |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||||||||||
| Net income (loss) | — | — | — | — |
(
|
— |
(
|
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income | — | — | — | — | — |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — |
|
— | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||||||||||
| Vesting of stock compensation awards |
|
— | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||
| Tax withholding on vesting of stock-based compensation awards |
(
|
— | — |
(
|
— | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||||||||||
| Common stock repurchased |
(
|
— |
(
|
— | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||||||||||
| Balance as of March 31, 2025 |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||||||||||
| Common Stock | APIC |
Retained
Earnings |
AOCIL |
Equity Before
NCI |
NCI |
Total
Equity |
||||||||||||||||||||||||||||||||||||||||||||
|
(Shares in thousands,
dollars in millions) |
Shares | Amount | ||||||||||||||||||||||||||||||||||||||||||||||||
| Balance as of December 31, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||||||
| Net income (loss) | — | — | — |
(
|
— |
(
|
|
(
|
||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss | — | — | — | — |
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — |
|
— | — |
|
— |
|
||||||||||||||||||||||||||||||||||||||||||
| Vesting of stock compensation awards |
|
— | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||
| Tax withholding on vesting of stock-based compensation awards |
(
|
— |
(
|
— | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||
| Balance as of March 31, 2024 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||||||
| Three Months Ended March 31, | ||||||||||||||||||||||||||
| (In millions) | 2025 | 2024 | ||||||||||||||||||||||||
| United Kingdom | $ |
|
$ |
|
||||||||||||||||||||||
| United States |
|
|
||||||||||||||||||||||||
| Netherlands |
|
|
||||||||||||||||||||||||
| France |
|
|
||||||||||||||||||||||||
| Spain |
|
|
||||||||||||||||||||||||
| Italy |
|
|
||||||||||||||||||||||||
| Other |
|
|
||||||||||||||||||||||||
| Total | $ |
|
$ |
|
||||||||||||||||||||||
| Three Months Ended March 31, | ||||||||||||||||||||||||||
| (In millions) | 2025 | 2024 | ||||||||||||||||||||||||
| Omnichannel retail | $ |
|
$ |
|
||||||||||||||||||||||
| Technology and consumer electronics |
|
|
||||||||||||||||||||||||
| Industrial and manufacturing |
|
|
||||||||||||||||||||||||
| Food and beverage |
|
|
||||||||||||||||||||||||
| Consumer packaged goods |
|
|
||||||||||||||||||||||||
| Other |
|
|
||||||||||||||||||||||||
| Total | $ |
|
$ |
|
||||||||||||||||||||||
| March 31, | December 31, | |||||||||||||
| (In millions) | 2025 | 2024 | ||||||||||||
| Contract assets and contract costs included in: | ||||||||||||||
| Other current assets | $ |
|
$ |
|
||||||||||
| Other long-term assets |
|
|
||||||||||||
| Total contract assets | $ |
|
$ |
|
||||||||||
| Contract liabilities included in: | ||||||||||||||
| Other current liabilities | $ |
|
$ |
|
||||||||||
| Other long-term liabilities |
|
|
||||||||||||
| Total contract liabilities | $ |
|
$ |
|
||||||||||
| Three Months Ended March 31, | ||||||||||||||||||||||||||
| (In millions) | 2025 | 2024 | ||||||||||||||||||||||||
|
Amounts included in the beginning of year contract liability balance
|
$ |
|
$ |
|
||||||||||||||||||||||
| Three Months Ended March 31, | ||||||||||||||||||||||||||
| (In millions) | 2025 | 2024 | ||||||||||||||||||||||||
| Revenue | $ |
|
$ |
|
||||||||||||||||||||||
| Direct operating expense |
|
|
||||||||||||||||||||||||
|
Selling, general and administrative expense
(1)
|
|
|
||||||||||||||||||||||||
|
Other (income), net
(2)
|
(
|
(
|
||||||||||||||||||||||||
| Segment Adjusted EBITDA | $ |
|
$ |
|
||||||||||||||||||||||
| Less: | ||||||||||||||||||||||||||
|
Corporate expenses
(3)
|
|
|
||||||||||||||||||||||||
| Depreciation expense |
|
|
||||||||||||||||||||||||
| Amortization of intangible assets acquired |
|
|
||||||||||||||||||||||||
| Transaction and integration costs |
|
|
||||||||||||||||||||||||
| Restructuring costs and other |
|
|
||||||||||||||||||||||||
| Regulatory matter and litigation expense |
|
|
||||||||||||||||||||||||
|
Unrealized (gain) loss on foreign currency contracts
(4)
|
|
(
|
||||||||||||||||||||||||
| Interest expense, net |
|
|
||||||||||||||||||||||||
| Loss before income taxes |
(
|
(
|
||||||||||||||||||||||||
| Income tax (expense) benefit |
(
|
|
||||||||||||||||||||||||
| Net loss | $ |
(
|
$ |
(
|
||||||||||||||||||||||
| March 31, | December 31, | |||||||||||||
| (In millions) | 2025 | 2024 | ||||||||||||
| Operating leases: | ||||||||||||||
| Operating lease assets | $ |
|
$ |
|
||||||||||
| Current operating lease liabilities | $ |
|
$ |
|
||||||||||
| Long-term operating lease liabilities |
|
|
||||||||||||
| Total operating lease liabilities | $ |
|
$ |
|
||||||||||
| Finance leases: | ||||||||||||||
| Property and equipment, net | $ |
|
$ |
|
||||||||||
| Current debt | $ |
|
$ |
|
||||||||||
| Long-term debt |
|
|
||||||||||||
| Total finance lease liabilities | $ |
|
$ |
|
||||||||||
| Three Months Ended March 31, | ||||||||||||||||||||||||||
| (In millions) | 2025 | 2024 | ||||||||||||||||||||||||
| Operating leases: | ||||||||||||||||||||||||||
| Operating lease cost | $ |
|
$ |
|
||||||||||||||||||||||
| Short-term lease cost |
|
|
||||||||||||||||||||||||
| Variable lease cost |
|
|
||||||||||||||||||||||||
|
Total operating lease cost
(1)
|
$ |
|
$ |
|
||||||||||||||||||||||
| Finance leases: | ||||||||||||||||||||||||||
| Amortization of leased assets | $ |
|
$ |
|
||||||||||||||||||||||
| Interest expense on lease liabilities |
|
|
||||||||||||||||||||||||
| Total finance lease cost | $ |
|
$ |
|
||||||||||||||||||||||
| Total operating and finance lease cost | $ |
|
$ |
|
||||||||||||||||||||||
| Three Months Ended March 31, | ||||||||||||||
| (In millions) | 2025 | 2024 | ||||||||||||
| Leased assets obtained in exchange for new lease obligations: | ||||||||||||||
| Operating leases | $ |
|
$ |
|
||||||||||
| Finance leases |
|
|
||||||||||||
| (In millions) | ||||||||
| ASSETS | ||||||||
| Current assets | ||||||||
| Cash and cash equivalents | $ |
|
||||||
| Accounts receivable |
|
|||||||
| Other current assets |
|
|||||||
| Total current assets |
|
|||||||
| Long-term assets | ||||||||
| Property and equipment |
|
|||||||
| Operating lease assets |
|
|||||||
|
Intangible assets
(1)
|
|
|||||||
| Other long-term assets |
|
|||||||
| Total long-term assets |
|
|||||||
| Total assets | $ |
|
||||||
| LIABILITIES | ||||||||
| Current liabilities | ||||||||
| Accounts payable | $ |
|
||||||
| Accrued expenses |
|
|||||||
| Current debt |
|
|||||||
| Current operating lease liabilities |
|
|||||||
| Other current liabilities |
|
|||||||
|
Total current liabilities
|
|
|||||||
| Long-term liabilities | ||||||||
| Long-term debt |
|
|||||||
| Long-term operating lease liabilities |
|
|||||||
| Other long-term liabilities |
|
|||||||
|
Total long-term liabilities
|
|
|||||||
| Total liabilities | $ |
|
||||||
| Net assets purchased | $ |
|
||||||
| Purchase price | $ |
|
||||||
|
Goodwill recorded
(2)
|
$ |
|
||||||
| (In millions) | ||||||||
|
Balance as of December 31, 2024
|
$ |
|
||||||
|
Acquisition
(1)
|
(
|
|||||||
|
Impact of foreign exchange translation
(2)
|
|
|||||||
|
Balance as of March 31, 2025
|
$ |
|
||||||
| March 31, | December 31, | |||||||||||||||||||
| (In millions, except percentages) |
Rate
(1)
|
2025 | 2024 | |||||||||||||||||
|
Unsecured notes due 2026
(2)
|
|
% | $ |
|
$ |
|
||||||||||||||
|
Unsecured notes due 2029
(3)
|
|
% |
|
|
||||||||||||||||
|
Unsecured notes due 2031
(4)
|
|
% |
|
|
||||||||||||||||
|
Unsecured notes due 2034
(5)
|
|
% |
|
|
||||||||||||||||
|
|
|
% |
|
|
||||||||||||||||
|
|
|
% |
|
|
||||||||||||||||
| Finance leases and other debt | Various |
|
|
|||||||||||||||||
| Total Debt |
|
|
||||||||||||||||||
| Less: Current debt |
|
|
||||||||||||||||||
| Total Long-term debt | $ |
|
$ |
|
||||||||||||||||
| Three Months Ended March 31, | ||||||||||||||||||||||||||
| (In millions) | 2025 | 2024 | ||||||||||||||||||||||||
| Receivables sold in period | $ |
|
$ |
|
||||||||||||||||||||||
| Cash consideration |
|
|
||||||||||||||||||||||||
|
Net cash provided by (used in) operating cash flows
|
(
|
|
||||||||||||||||||||||||
| March 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||||
| (In millions) | Level |
Fair
Value |
Carrying Value |
Fair
Value |
Carrying Value | |||||||||||||||||||||||||||
| Unsecured notes due 2026 | 2 | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
| Unsecured notes due 2029 | 2 |
|
|
|
|
|||||||||||||||||||||||||||
| Unsecured notes due 2031 | 2 |
|
|
|
|
|||||||||||||||||||||||||||
| Unsecured notes due 2034 | 2 |
|
|
|
|
|||||||||||||||||||||||||||
|
|
2 |
|
|
|
|
|||||||||||||||||||||||||||
|
|
2 |
|
|
|
|
|||||||||||||||||||||||||||
| March 31, 2025 | December 31, 2024 | Balance Sheet Location | ||||||||||||||||||||||||||||||
| (In millions) |
Notional Amount
|
Fair
Value |
Notional Amount
|
Fair
Value |
||||||||||||||||||||||||||||
|
Derivatives designated as net investment hedges:
|
||||||||||||||||||||||||||||||||
|
Cross-currency swap agreements
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
Other current assets | |||||||||||||||||||||||
| Cross-currency swap agreements |
|
|
|
|
Other long-term assets | |||||||||||||||||||||||||||
|
Cross-currency swap agreements
(2)(3)
|
|
|
|
|
Other current liabilities
|
|||||||||||||||||||||||||||
|
Cross-currency swap agreements
(3)
|
|
|
|
|
Other long-term liabilities | |||||||||||||||||||||||||||
| Derivatives designated as cash flow hedge: | ||||||||||||||||||||||||||||||||
|
Interest rate swaps
|
$ |
|
$ |
|
$ |
|
$ |
|
Other long-term assets | |||||||||||||||||||||||
| Derivatives not designated as hedges: | ||||||||||||||||||||||||||||||||
|
Foreign currency option contracts
(4)
|
$ |
|
$ |
|
$ |
|
$ |
|
Other current assets | |||||||||||||||||||||||
| Foreign currency option contracts |
|
|
|
|
Other current liabilities | |||||||||||||||||||||||||||
| Foreign currency forward contracts |
|
|
|
|
Other current assets | |||||||||||||||||||||||||||
| Foreign currency forward contracts |
|
|
|
|
Other current liabilities | |||||||||||||||||||||||||||
| Three Months Ended March 31, 2025 | Three Months Ended March 31, 2024 | |||||||||||||||||||||||||||||||||||||
| (In millions) | Amount of Gain (Loss) Recognized in Other Comprehensive Income on Derivative |
Gain (Loss) Reclassified from AOCIL into Net Income
(1)
|
Gain (Loss) Recognized in Net Income on Derivative (Excluded from effectiveness testing)
(1)
|
Amount of Gain (Loss) Recognized in Other Comprehensive Income on Derivative |
Gain (Loss) Reclassified from AOCIL into Net Income
(1)
|
Gain (Loss) Recognized in Net Income on Derivative (Excluded from effectiveness testing)
(1)
|
||||||||||||||||||||||||||||||||
| Derivatives designated as net investment hedges | ||||||||||||||||||||||||||||||||||||||
| Cross-currency swap agreements | $ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||
| Derivatives designated as cash flow hedges | ||||||||||||||||||||||||||||||||||||||
| Interest rate swaps | $ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||
| Three Months Ended March 31, | ||||||||||||||||||||||||||
| (In millions) | 2025 | 2024 | ||||||||||||||||||||||||
| Foreign currency gain (loss) on foreign currency contracts | $ |
(
|
$ |
|
||||||||||||||||||||||
| Three Months Ended March 31, | ||||||||||||||||||||||||||
|
(Dollars in millions, shares in thousands, except per share amounts)
|
2025 | 2024 | ||||||||||||||||||||||||
|
Net loss attributable to common shares
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||
| Basic weighted-average common shares |
|
|
||||||||||||||||||||||||
|
Diluted weighted-average common shares
|
|
|
||||||||||||||||||||||||
|
Basic loss per share
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||
|
Diluted loss per share
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||
|
Antidilutive shares excluded from diluted weighted-average common shares
|
|
|
||||||||||||||||||||||||
| Foreign Currency Adjustment | ||||||||||||||||||||||||||||||||||||||
| (In millions) |
Foreign
Currency Translation Adjustments |
Net Investment Hedges |
Cash
Flow Hedges |
Defined
Benefit Plans |
Less: AOCIL
attributable to NCI |
AOCIL
attributable to GXO |
||||||||||||||||||||||||||||||||
| As of December 31, 2024 | $ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
| Other comprehensive income (loss) before reclassifications |
|
(
|
(
|
(
|
(
|
|
||||||||||||||||||||||||||||||||
| Amounts reclassified to net income |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
| Tax amounts |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
| Other comprehensive income (loss), net of tax |
|
(
|
(
|
(
|
(
|
|
||||||||||||||||||||||||||||||||
| As of March 31, 2025 | $ |
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
| Foreign Currency Adjustment | ||||||||||||||||||||||||||||||||||||||
| (In millions) |
Foreign
Currency Translation Adjustments |
Net Investment Hedges |
Cash
Flow Hedges |
Defined
Benefit Plans |
Less: AOCIL
attributable to NCI |
AOCIL
attributable to GXO |
||||||||||||||||||||||||||||||||
| As of December 31, 2023 | $ |
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||||
| Other comprehensive income (loss) before reclassifications |
(
|
|
|
|
|
(
|
||||||||||||||||||||||||||||||||
| Amounts reclassified to net income (loss) |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
| Tax amounts |
|
(
|
|
|
|
(
|
||||||||||||||||||||||||||||||||
| Other comprehensive income (loss), net of tax |
(
|
|
|
|
|
(
|
||||||||||||||||||||||||||||||||
| As of March 31, 2024 | $ |
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
| Three Months Ended March 31, | ||||||||||||||||||||||||||
| (In millions) | 2025 | 2024 | ||||||||||||||||||||||||
| Interest cost | $ |
(
|
$ |
(
|
||||||||||||||||||||||
| Expected return on plan assets |
|
|
||||||||||||||||||||||||
| Amortization of prior service cost |
|
|
||||||||||||||||||||||||
| Amortization of net loss |
(
|
(
|
||||||||||||||||||||||||
|
Net periodic pension income
(1)
|
$ |
|
$ |
|
||||||||||||||||||||||
| Three Months Ended March 31, | ||||||||||||||||||||||||||
| (In millions) | 2025 | 2024 | ||||||||||||||||||||||||
|
Defined contribution costs
(1)
|
$ |
|
$ |
|
||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||
| Balance as of December 31, 2024 | $ |
|
||||||||||||||||||
| Charges incurred |
|
|||||||||||||||||||
| Payments |
(
|
|||||||||||||||||||
|
Balance as of March 31, 2025
|
$ |
|
||||||||||||||||||
| Three Months Ended March 31, | ||||||||||||||||||||||||||
| (In millions, except percentages) | 2025 | 2024 | $ Change | % Change | ||||||||||||||||||||||
| Revenue | $ | 2,977 | $ | 2,456 | $ | 521 | 21 | % | ||||||||||||||||||
| Direct operating expense | 2,558 | 2,056 | 502 | 24 | % | |||||||||||||||||||||
| Selling, general and administrative expense | 261 | 249 | 12 | 5 | % | |||||||||||||||||||||
| Depreciation and amortization expense | 109 | 92 | 17 | 18 | % | |||||||||||||||||||||
| Transaction and integration costs | 22 | 19 | 3 | 16 | % | |||||||||||||||||||||
| Restructuring costs and other | 17 | 16 | 1 | 6 | % | |||||||||||||||||||||
| Regulatory matter and litigation expense | 66 | 63 | 3 | 5 | % | |||||||||||||||||||||
| Operating loss | (56) | (39) | (17) | 44 | % | |||||||||||||||||||||
| Other income (expense), net | (5) | 6 | (11) | n/m | ||||||||||||||||||||||
| Interest expense, net | (32) | (13) | (19) | n/m | ||||||||||||||||||||||
| Loss before income taxes | (93) | (46) | (47) | n/m | ||||||||||||||||||||||
| Income tax (expense) benefit | (2) | 10 | (12) | n/m | ||||||||||||||||||||||
| Net loss | $ | (95) | $ | (36) | $ | (59) | n/m | |||||||||||||||||||
| Three Months Ended March 31, | ||||||||||||||||||||||||||
| (In millions, except percentages) | 2025 | 2024 | $ Change | % Change | ||||||||||||||||||||||
|
Net periodic pension income
|
$ | 5 | $ | 3 | $ | 2 | 67 | % | ||||||||||||||||||
| Foreign currency gain (loss): | ||||||||||||||||||||||||||
|
Realized foreign currency option and forward contracts loss
|
— | (1) | 1 | (100) | % | |||||||||||||||||||||
|
Unrealized foreign currency option and forward contracts gain (loss)
|
(10) | 3 | (13) | n/m | ||||||||||||||||||||||
|
Foreign currency transaction and remeasurement gain
|
— | 1 | (1) | (100) | % | |||||||||||||||||||||
| Total foreign currency gain (loss) | (10) | 3 | (13) | n/m | ||||||||||||||||||||||
| Other income (expense), net | $ | (5) | $ | 6 | $ | (11) | n/m | |||||||||||||||||||
| Three Months Ended March 31, | ||||||||||||||||||||||||||
| (In millions, except percentages ) | 2025 | 2024 | $ Change | % Change | ||||||||||||||||||||||
|
Debt and capital leases
|
$ | 43 | $ | 24 | $ | 19 | 79 | % | ||||||||||||||||||
|
Cross-currency swaps
|
(9) | (8) | (1) | 13 | % | |||||||||||||||||||||
|
Interest income
|
(2) | (3) | 1 | (33) | % | |||||||||||||||||||||
| Interest expense, net | $ | 32 | $ | 13 | $ | 19 | n/m | |||||||||||||||||||
| March 31, | December 31, | |||||||||||||||||||||||||
| (In millions, except percentages) | 2025 | 2024 | $ Change | % Change | ||||||||||||||||||||||
| Total current assets | $ | 2,629 | $ | 2,641 | $ | (12) | — | % | ||||||||||||||||||
| Total long-term assets | 8,693 | 8,625 | 68 | 1 | % | |||||||||||||||||||||
| Total current liabilities | 3,370 | 3,189 | 181 | 6 | % | |||||||||||||||||||||
| Total long-term liabilities | 5,048 | 5,042 | 6 | — | % | |||||||||||||||||||||
| Three Months Ended March 31, | ||||||||||||||||||||||||||
|
(In millions, except percentages)
|
2025 | 2024 |
$ Change
|
% Change
|
||||||||||||||||||||||
| Net cash provided by operating activities | $ | 29 | $ | 50 | $ | (21) | (42) | % | ||||||||||||||||||
| Net cash used in investing activities | (77) | (82) | 5 | (6) | % | |||||||||||||||||||||
| Net cash used in financing activities | (66) | (8) | (58) | n/m | ||||||||||||||||||||||
| Effect of exchange rates on cash and cash equivalents | 11 | (5) | 16 | n/m | ||||||||||||||||||||||
| Net decrease in cash, restricted cash and cash equivalents | $ | (103) | $ | (45) | $ | (58) | n/m | |||||||||||||||||||
| Period |
Total Number of Shares Purchased
(1)
|
Average Price Paid per Share
(2)
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs |
Approximate Dollar Value of Shares that may yet be Purchased under the Plans or Programs
(2)(3)
|
||||||||||||||||||||||
| January 1 - January 31 | — | $ | — | — | $ | — | ||||||||||||||||||||
| February 1 - February 28 | 481,658 | $ | 40.24 | 481,658 | $ | 480,617,226 | ||||||||||||||||||||
| March 1 - March 31 | 2,284,053 | $ | 39.53 | 2,284,053 | $ | 390,318,516 | ||||||||||||||||||||
| Total | 2,765,711 | $ | 39.66 | 2,765,711 | ||||||||||||||||||||||
|
Exhibit
Number |
Description | |||||||
| 10.1+ | ||||||||
| 10.2*+ | ||||||||
| 10.3*+ | ||||||||
| 31.1* | ||||||||
| 31.2* | ||||||||
| 32.1** | ||||||||
| 32.2** | ||||||||
| 101.INS* | Inline XBRL Instance Document. | |||||||
| 101.SCH* | Inline XBRL Taxonomy Extension Schema. | |||||||
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase. | |||||||
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase. | |||||||
| 101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase. | |||||||
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase. | |||||||
| 104* | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). | |||||||
| * | Filed herewith. | |||||||
| ** | Furnished herewith. | |||||||
| + | This exhibit is a management contract or compensatory plan or arrangement. | |||||||
|
GXO Logistics, Inc.
|
||||||||
|
Date:
May 8, 2025
|
By: |
/s/ Malcolm Wilson
|
||||||
| Malcolm Wilson | ||||||||
| (Chief Executive Officer) | ||||||||
|
(Principal Executive Officer)
|
||||||||
|
Date: May 8, 2025
|
By: |
/s/ Baris Oran
|
||||||
| Baris Oran | ||||||||
| (Chief Financial Officer) | ||||||||
|
(Principal Financial Officer)
|
||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|